Introducing Point-of-Care Testing for Hepatitis C
New York State’s Hepatitis C Dashboard shows that in 2023, 4,783 people were newly diagnosed with HCV in the state, an 8% decrease from 2022. Incidence also decreased, with the rate of new HCV infecti...
14 Touko 21min
Cannabis and Pregnancy
Based on data from 2023-24, roughly 23% of New Yorkers aged 21 or older reported cannabis use in the past 12 months. Although men generally have a higher prevalence of use than women, recent studies s...
20 Huhti 22min
CROI 2026 – Live from Denver: What You Need to Know
Conference on Retroviruses and Opportunistic Infections (CROI) 2026 took place from February 22 to 25 in Denver, Colorado. CROI is an annual scientific meeting devoted to the understanding, prevention...
7 Huhti 15min
What “The 72-Hour Rule” Update Means for New York State
Effective February 19, 2026, New York State law permits clinicians to dispense up to 72 hours (equivalent to a 3-day supply) of controlled substances, such as methadone and buprenorphine, for the mana...
17 Helmi 19min
Two New Treatments for Gonorrhea; one is available now!
In this episode of the Conversations with CEI, infectious disease specialist Dr. Steven Fine delves into groundbreaking advancements in the treatment of urogenital gonorrhea. The episode highlights th...
12 Tammi 15min
PrEParing for Lenacapavir Implementation in Your Clinic: Early Lessons Learned
On June 18, 2025, the FDA approved Yeztugo, the brand name for subcutaneous lenacapavir, a prescription medication used for the pre-exposure prophylaxis of HIV. Subcutaneous lenacapavir is administer...
20 Marras 202528min
Keeping an Eye on STIs – Have You Heard of TMVII?
This month, host Dr. Marguerite Urban chats with Dr. Jason Zucker, an adult and pediatric infectious diseases physician at Columbia University and the assistant medical director of the New York City H...
13 Marras 202518min
